# Spectral Analysis Probe to Identify Glioblastoma Cells

> **NCT03293888** · — · TERMINATED · sponsor: **University of Oklahoma** · enrollment: 12 (actual)

## Conditions studied

- Glioblastoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03293888
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-31
- **Primary completion:** 2018-09-30
- **Final completion:** 2018-09-30
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** PI Relocation
- **Last updated:** 2019-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03293888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03293888, "Spectral Analysis Probe to Identify Glioblastoma Cells". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03293888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*